US2022127298A1PendingUtilityA1

Thermosporothrix hazakensis-derived antibacterially active substance

Assignee: KENNAN EISEI KOGYO CO LTDPriority: Feb 4, 2019Filed: Feb 4, 2020Published: Apr 28, 2022
Est. expiryFeb 4, 2039(~12.5 yrs left)· nominal 20-yr term from priority
Y02A50/30A61K 35/74A01P 1/00A01N 45/02C07H 15/244A61K 31/704A01N 63/20C12P 17/16A61P 31/04C07D 307/20A01N 43/08
40
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides a novel compound having an antibacterial activity, and a method for producing the same. The compound is represented by Formula (I): or a salt or ester thereof.

Claims

exact text as granted — not AI-modified
1 . A compound represented by Formula (I): 
       
         
           
           
               
               
           
         
       
       or a salt or ester thereof. 
     
     
         2 . A compound having an absorption maximum at 340 nm in its UV spectrum, and a molar absorption coefficient of 30630;
 having a molecular formula of C 74 H 58 Cl 8 O 26  as determined by analyses of an ESI/TOF/MS spectrum and a high-resolution mass spectrum;   showing signals at δ11.49, 10.92, 6.67, 6.41, 6.21, 6.00, 5.91, 4.95, 4.26, 3.96, 3.95, 3.79, 3.71, 3.70, 2.69, 2.19, and 0.90 in a  1 H NMR spectrum (DMSO-d 6 ); and   showing signals at δ188.61, 184.49, 162.20, 159.96, 158.11, 155.76, 155.25, 150.91, 140.73, 140.25, 140.25, 138.20, 137.79, 137.26, 134.60, 133.53, 132.77, 125.42, 121.51, 120.24, 119.19, 114.71, 111.89, 109.54, 102.99, 99.78, 98.55, 77.15, 72.75, 70.21, 67.00, 61.20, 60.68, 56.94, 17.83, 15.90, and 14.96 in a  13 C NMR spectrum (DMSO-d 6 );   or a salt or ester thereof.   
     
     
         3 . The compound, or a salt or ester thereof according to  claim 2 , obtained by culturing  Thermosporothrix hazakensis  in a culture medium, and recovering the compound, or a salt or ester thereof from the culture product. 
     
     
         4 . The compound, or a salt or ester thereof according to  claim 3 , wherein the compound, or a salt or ester thereof is recovered by treating an ethyl acetate extract with a silica gel column, the ethyl acetate extract being obtained by partitioning an aqueous acetone solution extract of the culture product between ethyl acetate and water. 
     
     
         5 . The compound, or a salt or ester thereof according to  claim 3 , wherein  Thermosporothrix hazakensis  is a  Thermosporothrix hazakensis  SK20-1 T  strain. 
     
     
         6 . A method of producing the compound, or a salt or ester thereof according to  claim 1 , comprising a step of culturing  Thermosporothrix hazakensis  in a culture medium, and recovering the compound, or a salt or ester thereof from the culture product. 
     
     
         7 . The method according to  claim 6 , wherein the compound, or a salt or ester thereof is recovered by treating an ethyl acetate extract with a silica gel column, the ethyl acetate extract being obtained by partitioning an aqueous acetone solution extract of the culture product between ethyl acetate and water. 
     
     
         8 . The method according to  claim 6 , wherein  Thermosporothrix hazakensis  is a  Thermosporothrix hazakensis  SK20-1 T  strain. 
     
     
         9 . An antibacterial agent comprising the compound, or a salt or ester thereof according to  claim 1 , as an active ingredient. 
     
     
         10 . An antibacterial agent comprising the compound, or a salt or ester thereof according to  claim 2 , as an active ingredient. 
     
     
         11 . A method of inhibiting bacterial growth, comprising contacting a bacteria with an effective amount of the compound, or a salt or ester thereof of  claim 1 . 
     
     
         12 . A method of inhibiting bacterial growth, comprising contacting a bacteria with an effective amount of the compound, or a salt or ester thereof of  claim 2 . 
     
     
         13 . The method of  claim 11 , wherein the bacteria is selected from the group consisting of:  Geobacillus stearothermophilus, Bacillus subtilis, Streptomyces griseus, Escherichia coli, Thermosporothrix hazakensis, Thermosporothrix narukonensis , and  Streptomyces  sp. 
     
     
         14 . The method of  claim 12 , wherein the bacteria is selected from the group consisting of:  Geobacillus stearothermophilus, Bacillus subtilis, Streptomyces griseus, Escherichia coli, Thermosporothrix hazakensis, Thermosporothrix narukonensis , and  Streptomyces  sp.

Join the waitlist — get patent alerts

Track US2022127298A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.